Johnson & Johnson to acquire Shockwave Medical for $13.1B
Johnson & Johnson (NYSE: JNJ) announced today that it agreed to acquire Shockwave Medical (Nasdaq:SWAV) for approximately $13.1 billion.
Stay updated with breaking news from Michael Bodner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Johnson & Johnson (NYSE: JNJ) announced today that it agreed to acquire Shockwave Medical (Nasdaq:SWAV) for approximately $13.1 billion.
Enhances Johnson & Johnson’s Ability to Transform the Treatment Landscape for Cardiovascular Disease and Continue to Improve Patient Outcomes Extends Johnson & Johnson MedTech’s Position in...
Drug major Johnson & Johnson (JNJ) announced Friday its agreement to acquire Shockwave Medical, Inc. (SWAV) for $335.00 per share in cash. The enterprise value of the deal is around $13.
Nearly a quarter of the way through 2023, we've seen plenty of movement in the personnel department across medtech.
Lynchburg City Council is beginning to announce interviewees for three seats on the Lynchburg City School Board that are set to expire on June 30, closing the application portion of